Connecting you to content on EBSCOhost

Works matching IS 10109609 AND DT 2002 AND VI 16 AND IP 1

Results: 46

1

Annex 2.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 2
Publication type:: Article

2

Annex 1.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 71
Publication type:: Article

3

International Nonproprietary Names for Pharmaceutical Substances (INN).

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 37
Publication type:: Article

4

REOMMENDED International Nonproprietary Names (Rec. INN): List 47.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 81
Publication type:: Article

5

International Nomproprietary Names for Pharmaceutical Substances (INN).

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 37
Publication type:: Article

6

The information gap: new resource for developing countries.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 36
Publication type:: Article

7

Direct to consumer advertising.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 36
Publication type:: Article

8

WHO Model Formulary now available.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 35
Publication type:: Article

9

WHO Guidelines on stability testing.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 35
Publication type:: Article

10

List of pre-qualified products - 20 March 2002.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 33
Publication type:: Article

11

Current status of the project.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 31
Publication type:: Article

12

Pilot Procurement Project for Quality and Sourcing (Pre-qualification) of HIV/AIDS drugs.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 31
Publication type:: Article

13

Correction:.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 30
Publication type:: Article

14

Sodium phosphate oral solution: electrolyte balance disturbance.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 30
Publication type:: Article

15

Recommended influenza virus vaccine composition.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 29
Publication type:: Article

16

Stavudine: neuromuscular weakness.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 29
Publication type:: Article

17

Methotrexate: interactions.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 29
Publication type:: Article

18

Clozapine and myocarditis.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 28
Publication type:: Article

19

Acarbose, zafirlukast and vincristine: revised precautions.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 28
Publication type:: Article

20

Nefazodone: rare cases of liver failure.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 28
Publication type:: Article

21

Alfa interferons: labelling change.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 27
Publication type:: Article

22

Cyproterone with ethinylestradiol: risk of venous thromboembolism.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 27
Publication type:: Article

23

Sibutramine safety review.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 26
Publication type:: Article

24

Hua Fo: unknown substance.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 26
Publication type:: Article

25

Paroxetine: severe withdrawal symptoms.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 26
Publication type:: Article

26

Zolpidem and neurological reactions.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 25
Publication type:: Article

27

Rofecoxib interaction with warfarin.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 25
Publication type:: Article

28

Kava kava: investigations into liver injury.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 24
Publication type:: Article

29

Kava kava products and potential liver injury.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 24
Publication type:: Article

30

Ziprasidone hydrochloride: labelling clarifications.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 23
Publication type:: Article

31

Enoxaparin sodium Injection: new safety warnings.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 23
Publication type:: Article

32

Mother to child transmission of HIV: WHO statement.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 22
Publication type:: Article

33

Review of HIVNET 012.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 21
Publication type:: Article

34

Nevirapine: comments on HIVNET 012 from the manufacturer.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 21
Publication type:: Article

35

Internet sales and reimbursement by insurance companies.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 20
Publication type:: Article

36

Progress in pharmacogenetics and pharmacogenomics*.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 17
Publication type:: Article

37

Lipodystrophy syndrome under-reported.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 16
Publication type:: Article

38

Haemolysis after consumption of Viola tricolor.

Published in:

WHO Drug Information, 2002, v. 16, n. 1, p. 15

By:

Behmanesh, Yasna;
Abdollahi, Mohammad

Publication type:

Article

39

Endocrinotoxicity induced by Coriandrum sativa: a case report.

Published in:

WHO Drug Information, 2002, v. 16, n. 1, p. 15

By:

Zabihi, Ebrahim;
Abdollahi, Mohammad

Publication type:

Article

40

Alendronate: link with pancreatitis?

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 15
Publication type:: Article

41

Amiodarone and pulmonary toxicity.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 14
Publication type:: Article

42

The COX-2 inhibitors.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 12
Publication type:: Article

43

International Conference on Harmonization (ICH): pharmacovigilance activities.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 11
Publication type:: Article

44

WHO international drug monitoring: cerivastatin and gemfibrozil.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 8
Publication type:: Article

45

International reference materials for Creutzfeldt-Jakob disease.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 3
Publication type:: Article

46

WHO position on rabies vaccine.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 4
Publication type:: Article